COVID-related transaminitis confounding toxicity attribution in a child with brain tumour on targeted therapy

Pediatr Blood Cancer. 2023 Mar;70(3):e29987. doi: 10.1002/pbc.29987. Epub 2022 Oct 17.

Authors

Fernando Carceller^{1

2}, Elizabeth A Corley¹, Andrew King³, Bassel Zebian⁴, Henry C Mandeville^{2

5}, Lynley V Marshall^{1

2}

Affiliations

¹ Paediatric & Adolescent Drug Development Unit, The Royal Marsden NHS Foundation Trust, London, UK.
² Division of Clinical Studies, The Institute of Cancer Research, London, UK.
³ Department of Clinical Neuropathology, King's College Hospital, London, UK.
⁴ Department of Neurosurgery, King's College Hospital, London, UK.
⁵ Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Brain Neoplasms* / complications
Brain Neoplasms* / drug therapy
COVID-19* / complications
Chemical and Drug Induced Liver Injury*
Child
Humans